| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | See Remarks
3 companies
Moulder Leon O Jr is a Director at DNTH, with reported holdings spanning 3 companies. Recent filings cover 19 purchases and 0 sales. Those positions are worth an estimated $18.9M at current prices.
Our model assigns Moulder Leon O Jr a strong insider score of 83/100, based on 16 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +64.6%.
Moulder Leon O Jr's largest disclosed position is in DNTH as Director, worth about $17.2M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 60,000 | $16.88 | $1,012,800.00 | +162.5% | +80.4% | - | |
| Apr 29, 2026 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 60,000 | $17.79 | $1,067,200.00 | +3.5% | +84.0% | - | |
| Mar 31, 2026 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 54,000 | $18.91 | $1,021,140.00 | +3.2% | +30.7% | - | |
| Feb 2, 2026 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 57,000 | $17.96 | $1,023,720.00 | +15.6% | +18.8% | - | |
| Jan 9, 2026 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 100,000 | $16.39 | $1,639,000.00 | +37.6% | +32.3% | - | |
| Oct 7, 2025 | ZBIO Zenas Biopharma, Inc. | See Remarks | Buy | 36,928 | $20.85 | $769,948.80 | New | -20.3% | +35.2% | |
| Feb 18, 2025 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 25,000 | $6.67 | $166,750.00 | +10.4% | +65.6% | +301.2% | |
| Dec 4, 2024 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 70,000 | $10.26 | $718,100.00 | +40.9% | -29.6% | +287.3% | |
| Nov 19, 2024 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 10,000 | $14.89 | $148,925.00 | +6.2% | -54.1% | +156.2% | |
| Sep 20, 2024 | ZBIO Zenas Biopharma, Inc. | Chief Executive Officer | Buy | 20,000 | $18.04 | $360,819.97 | +1.2% | -48.6% | -0.3% |